Find a Clinical Trial

HER2 Negative Breast Cancer

HCRN-BRE20-468 - A Phase II Study of Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (RaPhLRR Study)

18+

Learn more

HIP ATTACK-2

HIP Fracture Accelerated surgical TreaTment And Care tracK 2 (HIP ATTACK-2) Trial

45+

Learn more

Home and Bedside Visual Fields

Home and Bedside Visual Field Testing with Oleyes VisuALL Device

15-80

Learn more

Home Cooking Patterns and IBD

Home Cooking Patterns and Inflammatory Bowel Disease

18-89

Learn more

Patient participation to donate blood for laboratory analysis

IgA Protease Treatment for IgA Nephropathy

18-75

Learn more

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA)

IMGN857-0421, Randomized, Multicenter, Open-label, Phase 3 Study of Mirvetuximab Soravtansine in Combination With Bevacizumab Versus Bevacizumab Alone as Maintenance Therapy for Patients With FRα-high Recurrent Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers Who Have Not Progressed After Second Line Platinum-based Chemotherapy Plus Bevacizumab (GLORIOSA)

18+

Learn more

Protect IV

Impella® Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial

18-90

Learn more

DEcIDED

Intracanalicular Dexamethasone Insert for the Treatment of Inflammation and Discomfort in Dry Eye Disease

18+

Learn more

Multi-spectral imaging

Label-free, multi-scale imaging for improved detection of ovarian cancer metastases

18-99

Learn more

LIPP

Lifestyle Intervention in Preparation for Pregnancy (LIPP)

18-45

Learn more